Literature DB >> 24507940

Low preoperative fibrinogen plasma concentration is associated with excessive bleeding after cardiac operations.

Katarina Waldén1, Anders Jeppsson2, Salmir Nasic3, Erika Backlund1, Martin Karlsson4.   

Abstract

BACKGROUND: Data from small selected patient populations suggest that the preoperative plasma concentration of fibrinogen influences postoperative blood loss and red blood cell transfusion after cardiac operations, but there are also conflicting reports. We assessed the importance of preoperative fibrinogen concentration for excessive bleeding and red cell blood transfusion in a large cohort of mixed cardiac surgical patients.
METHODS: We included 1,954 cardiac surgical patients in a prospective observational study. The fibrinogen plasma concentration was measured on the day before the operation. Blood loss (mediastinal drain volume) during the first 12 postoperative hours and red blood cell transfusion during the hospital stay were registered and related to fibrinogen concentration with logistic regression models. Excessive bleeding was defined as postoperative blood loss exceeding 1,000 mL/12 hours.
RESULTS: The preoperative fibrinogen concentration was inversely proportional to the prevalence of excessive bleeding in univariate testing (odds ratio [OR], 0.75; 95% confidence interval [CI], 0.64 to 0.89 per g/L; p=0.001) and also in a multiple model adjusted for age, sex, body mass index, renal function, acuteness of the operation, cardiopulmonary bypass time, clopidogrel use less than 5 days before the operation, and type of operation (OR for fibrinogen, 0.82; 95% CI, 0.69 to 0.97; p=0.024). In contrast, the prevalence of red cell blood transfusion increased with increasing fibrinogen levels in univariate testing (OR, 1.36; 95% CI, 1.24 to 1.49; p<0.001) but not in a multiple model (OR, 1.10; 95% CI, 0.89 to 1.28; p=0.49).
CONCLUSIONS: Preoperative plasma concentration of fibrinogen is independently associated with excessive bleeding after cardiac operations but not with red blood cell transfusion.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24507940     DOI: 10.1016/j.athoracsur.2013.11.064

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  The incidence and risk factors of hypofibrinogenemia in cardiovascular surgery.

Authors:  Toshihiko Nishi; Masato Mutsuga; Toshiaki Akita; Yuji Narita; Kazuro Fujimoto; Yoshiyuki Tokuda; Sachie Terazawa; Hideki Ito; Kimitoshi Nishiwaki; Akihiko Usui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-09-17

2.  Updates on coagulation management in cardiac surgery.

Authors:  Mahdi Najafi; David Faraoni
Journal:  J Tehran Heart Cent       Date:  2014

3.  Prediction of Post-Weaning Fibrinogen Status during Cardiopulmonary Bypass: An Observational Study in 110 Patients.

Authors:  Gabor Erdoes; Germaine Gerster; Giuseppe Colucci; Heiko Kaiser; Lorenzo Alberio; Balthasar Eberle
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

4.  Impact of the intraoperative use of fibrinogen concentrate for hypofibrinogenemia during thoracic aortic surgery.

Authors:  Yoshimori Araki; Akihiko Usui; Hideki Oshima; Tomonobu Abe; Kazuro Fujimoto; Masato Mutsuga; Yoshiyuki Tokuda; Sachie Terazawa; Kei Yagami; Hideki Ito
Journal:  Nagoya J Med Sci       Date:  2015-02       Impact factor: 1.131

5.  Tabula viva chirurgic: a living surgical document.

Authors:  Marius J Swart; Gina Joubert; Jan-Albert van den Berg; Gert J van Zyl
Journal:  Cardiovasc J Afr       Date:  2016 May/Jun       Impact factor: 1.167

6.  Crotalus atrox venom preconditioning increases plasma fibrinogen and reduces perioperative hemorrhage in a rat model of surgical brain injury.

Authors:  Cherine H Kim; Devin W McBride; Ronak Raval; Prativa Sherchan; Karen L Hay; Eric C K Gren; Wayne Kelln; Tim Lekic; William K Hayes; Brian S Bull; Richard Applegate; Jiping Tang; John H Zhang
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

7.  Diagnostic evaluation of risk for bleeding in cardiac surgery with extracorporeal circulation.

Authors:  Damaris Vieira Braga; Marcos Antônio Gomes Brandão
Journal:  Rev Lat Am Enfermagem       Date:  2018-11-29

8.  Evaluation of Plasma Fibrinogen Levels before and after Coronary Artery Bypass Graft Surgery and Its Association with the Need for Blood Products.

Authors:  Azim Honarmand; Keivan Bagheri; Alireza Hoghooghy; Kazem Rezaei
Journal:  Adv Biomed Res       Date:  2022-03-30

9.  Short-term recovery pattern of plasma fibrinogen after cardiac surgery: A prospective observational study.

Authors:  Gabor Erdoes; Wulf Dietrich; Monika Pia Stucki; Tobias Michael Merz; Anne Angelillo-Scherrer; Michael Nagler; Thierry Carrel; Balthasar Eberle
Journal:  PLoS One       Date:  2018-08-03       Impact factor: 3.240

10.  A Low-dose human fibrinogen is not effective in decreasing postoperative bleeding and transfusion requirements during cardiac surgery in case of concomitant clinical bleeding and low FIBTEM values: A retrospective matched study.

Authors:  Iuliana-Marinela Lupu; Zineb Rebaine; Laurence Lhotel; Christine Watremez; Stéphane Eeckhoudt; Michel Van Dyck; Mona Momeni
Journal:  Ann Card Anaesth       Date:  2018 Jul-Sep
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.